final dynamic clinicalPsychology = {
  "itemName": "Clinical Psychology",
  "imageFolder": "CLINICAL_PSYCHOLOGY",
  "entries": [
    {
      "title": "Definition",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "The branch of psychology concerned with the assessment and treatment of mental illness and psychological problems."
        }
      ]
    },
    {
      "title": "Principles of holistic medicine",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• practitioners believe that the whole person is made up of interdependent parts and if one part is not working properly, all the other parts (overall health) will be affected"
        },
        {
          "value":
              "• treatment plan may involve drugs + lifestyle modifications (CHIRPU)"
        },
        {
          "value":
              "• 1. belief - unconditional love and support is the most powerful healer"
        },
        {
          "value":
              "• 2. the indiv is ultimately responsible for their own health and well-being"
        },
        {"value": "• 3. people have innate healing powers"},
        {"value": "• 4. patient is a person, not a disease"},
        {
          "value":
              "• 5. addresses all aspects of a person's life using a variety of health care practices"
        },
        {
          "value":
              "• 6. treatment involves fixing the cause of the condition, not just alleviating the symptoms"
        }
      ]
    },
    {
      "title": "Separation Anxiety Disorder",
      "type": "NORMAL",
      "data": [
        {"value": "• symptoms"},
        {"value": "• treatment"},
        {"value": "• stigma"}
      ]
    },
    {
      "title": "Separation Anxiety Disorder",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "symptoms"},
            {
              "value":
                  "refusing to sleep alone, nightmares with theme of seperation, intesnst worry when away from home/family, refusing to go to school"
            }
          ]
        },
        {
          "columns": [
            {"value": "treatment"},
            {"value": "psychotherapy, medication (SSRIs)"}
          ]
        },
        {
          "columns": [
            {"value": "stigma"},
            {
              "value":
                  "diminished self-worth and confidence, feel socially disconnected from peers"
            }
          ]
        },
        {
          "columns": [
            {"value": "examples"},
            {
              "value":
                  "being left at daycare, entering school, left with abysitters, staying overnight at someone's house"
            }
          ]
        }
      ]
    },
    {
      "title": "panic disorder",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "symptoms"},
            {
              "value":
                  "pounding/racing heart, sweating, chills, trembling, breathing problems,  sense of impending doom, fear of loss of control or death"
            }
          ]
        },
        {
          "columns": [
            {"value": "treatment"},
            {"value": "talk therapy, CBT, SSRIs, SNRIs"}
          ]
        },
        {
          "columns": [
            {"value": "stigma"},
            {"value": "overreacting, emotionally fragile or unstable"}
          ]
        },
        {
          "columns": [
            {"value": "examples"},
            {
              "value":
                  "worrying they will faint, embarrass themselves, have a heart attack, die, go crazy"
            }
          ]
        }
      ]
    },
    {
      "title": "generalized anxiety disorder",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "symptoms"},
            {
              "value":
                  "Feeling restless, wound-up, or on-edge, Being easily fatigued, Having difficulty concentrating; mind going blank, Being irritable, Having muscle tension, Difficulty controlling feelings of worry"
            }
          ]
        },
        {
          "columns": [
            {"value": "treatments"},
            {
              "value":
                  "talk therapy or psychological counseling, antidepressants"
            }
          ]
        },
        {
          "columns": [
            {"value": "stigma"},
            {
              "value":
                  "suffer serious social or professional problems, being seen as “crazy” or “insane”"
            }
          ]
        },
        {
          "columns": [
            {"value": "examples"},
            {
              "value":
                  "minor matters (will I arrive on time?) health and safety of loved ones, personal health and safety, work or school, money and paying bills, appearance, friendships and relationships, community affairs, politics, the environment"
            }
          ]
        }
      ]
    },
    {
      "title": "Anxiety disorder due to another medical condition",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "symptoms"},
            {
              "value":
                  "muscle tension, heart palpitations, sweating, dizziness, or difficulty catching the breath"
            }
          ]
        },
        {
          "columns": [
            {"value": "treatments"},
            {"value": "medications, psychotherapy"}
          ]
        },
        {
          "columns": [
            {"value": "stigma"},
            {"value": "being seen as weak or crazy, seen as any other issue"}
          ]
        },
        {
          "columns": [
            {"value": "examples"},
            {"value": "panic attack that leads to heart attack"}
          ]
        }
      ]
    },
    {
      "title": "substance/medication-induced anxiety disorder",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "symptoms"},
            {
              "value":
                  "have to be causing a great deal of emotional upset or significantly affecting the person's life, including their work or social life, or another part of their life that is important"
            }
          ]
        },
        {
          "columns": [
            {"value": "treatments"},
            {"value": "SoAD, SSRIs"}
          ]
        },
        {
          "columns": [
            {"value": "stigma"},
            {
              "value":
                  "inability to afford the cost of care, believing that the problems could be handled without treatment, not knowing where to go for services, concerns about confidentiality, that it might cause neighbors or the community to have a negative opinion, that it might cause a negative effect on a person's job, fear of being committed, inadequate or no coverage of mental health treatme, and thinking that treatment would not help"
            }
          ]
        },
        {
          "columns": [
            {"value": "examples"},
            {
              "value":
                  "Substance-induced delirium Substance-induced persisting dementia Substance-induced persisting amnestic disorder Substance-induced psychotic disorder Substance-induced mood disorder Substance-induced anxiety disorder Hallucinogen persisting perceptual disorder Substance-induced sexual dysfunction Substance-induced sleep disorder"
            }
          ]
        }
      ]
    },
    {
      "title": "THERAPY - Biological Medical Approach",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• Rely on drugs or surgery. Alter the way brain functions\n\nDepression - low serotonin neurotransmitter\nAnti-depressants (Prozac, Pail, Zoloft) prevent re-uptake of serotonin (SSRI) result in elevated mood\n\nAnti-anxiety drugs (Librium, Valium) reduce arousal, depress activity in CNS\n\nAnti-psychotics (Clozapine, Thorazine) treat symptoms of schizophrenia. block operation of neurotransmitter dopamine\n\nBarbiturates (tranquilizer) (opiate)\n\nOpiates - opium, decreases nervous system, addictive, side effects"
        }
      ]
    },
    {
      "title": "Symptoms of Groupthink",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• 1) illusion if invulnerability \n2) self-censorship\n3) pressure on dissenters to conform \n4) an illusion of unamity"
        }
      ]
    },
    {
      "title": "Psychological Disorders - Origins",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• Medical - caused by biological reasons (injury, genetics, drugs)\n\nPsychoanalytic - childhood conflicts, unconscious, misdirected anger\n\nCognitive - patterns of thinking are abnormal, success because of others (luck, generous), fail because of self (stupid, no talent)\n\nLearn/Behavior - problem behavior is the problem, some type of classical conditioning or reinforcement has occurred for behavior to continue"
        }
      ]
    },
    {
      "title": "Prospagnosia",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• HERE is a very interesting article about Prosopagnosia (Face Blindness)."
        },
        {
          "value":
              "• Includes information about: Broca, Wernicke, deja vu, Capgras syndrome\n\nBy Oliver Sacks"
        }
      ]
    },
    {
      "title": "Psychological Disorders",
      "type": "NORMAL",
      "data": [
        {"value": "• "}
      ],
      "youtube": "wuhJ-GkRRQc"
    },
    {
      "title": "Diathesis-Stress Theory",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• Genetic predisposition (diathesis) + environmental factors (stress) = mood disorders"
        }
      ],
      "image": "DIATHESIS_STRESS_THEORY"
    },
    {
      "title": "Sigmund Freud",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• 1886 specialized in nervous disorders (talking cure)\nfree associate\n\nUber Coca 1st publication (about benefits of cocaine)\n\n1900 interpretation of dreams psychoanalysis\n\nID - pleasure principle (immediate gratification, impulsive) (devil)\nEGO - reality principle (mediates between id & superego) (self)\nSUPEREGO - morality principle (social part, get along with others) (angel)\n\nPhobia - cause when you want something you can't have"
        }
      ],
      "image": "SIGMUND_FREUD"
    },
    {
      "title": "FREUD - Psychosexual Stages",
      "type": "NORMAL",
      "data": [
        {
          "value":
              "• Psychosexual stages\n1. Oral stage\n2. Anal stage\n3. Phallic stage\n\n"
        }
      ],
      "youtube": "ZWucNQawpWY"
    },
    {
      "title": "Obesity prevention",
      "type": "NORMAL",
      "data": [
        {"value": "• How do we measure obesity?"},
        {"value": "• Trends in obesity"},
        {"value": "• Problems associated with obesity"},
        {"value": "• What are some contributing factors to obesity?"},
        {"value": "• Lifestyle factors contributing to obesity"},
        {"value": "• Obesogenic environment"},
        {"value": "• Biological factors contributing to obesity"},
        {"value": "• Why is childhood obesity a concern?"},
        {
          "value":
              "• Good for Kids, Good for Life programme targeted behaviours"
        },
        {
          "value":
              "• Good for Kids, Good for Life programme key characteristics"
        },
        {"value": "• Good for Kids, Good for Life programme trials"},
        {"value": "• process-settings based change"},
        {
          "value":
              "• theoretical domains framework:\n• Knowledge –\n• Skills\n• Social/professional role and identity \n• Beliefs about capabilities \n• Optimism \n• Beliefs about consequences \n• Reinforcement \n• Intentions\n• Goals \n• Memory, attention and decision processes \n• Environmental context and resources \n• Social influences \n• Emotion \n• Behavioural regulation"
        }
      ]
    },
    {
      "title": "Alcohol Related Harm",
      "type": "NORMAL",
      "data": [
        {"value": "• How does alcohol cause harm?"},
        {"value": "• Alcohol is"},
        {"value": "• Acute vs chronic harm"},
        {"value": "• Australian guidelines"},
        {"value": "• Approaches to prevention (Barbor, 2010)"},
        {"value": "• Most effective"},
        {"value": "• Least effective"},
        {"value": "• Underpinnings of the current national policy approach"},
        {"value": "• 1 standard drink = 10g of alcohol"}
      ]
    },
    {
      "title": "Smoking Cessation",
      "type": "NORMAL",
      "data": [
        {"value": "• Smoking related morbidity and mortality"},
        {"value": "• At risk groups"},
        {"value": "• Why is quitting harder for some?"},
        {"value": "• Two main approaches"},
        {"value": "• Public health and legislative approaches"},
        {"value": "• Clinical prevention"},
        {"value": "• (Clinical) Behavioural therapies"},
        {"value": "• What works best?"}
      ]
    },
    {
      "title": "KETAMINE",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Mechanism of action:"},
            {
              "value":
                  "non-competitive NMDA receptor antagonist. Inhibition of catecholamine reuptake."
            }
          ]
        },
        {
          "columns": [
            {"value": "Side effects:"},
            {
              "value":
                  "High blood pressure, nausea, vomiting, addiction, perceptual disturbances, dissociation. Drug of abuse."
            }
          ]
        }
      ]
    },
    {
      "title": "MAOI",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Mechanism of action:"},
            {"value": "monoamine oxidase (MAO) inhibition."}
          ]
        },
        {
          "columns": [
            {"value": "Side effects:"},
            {
              "value":
                  "blockade of tyramine metabolism, interaction with diet, atropine-like effects."
            }
          ]
        },
        {
          "columns": [
            {"value": "Other side effects:"},
            {"value": "weight gain, insomnia, nervousness."}
          ]
        },
        {
          "columns": [
            {"value": "MOCLOBEMIDE, CLORGILINA:"},
            {"value": "selective, competitive and reversible MAO-A inhibition."}
          ]
        },
        {
          "columns": [
            {"value": "PHENELZINE, TRANYLCYPROMINE, IPRONIAZIDE:"},
            {
              "value":
                  "non-selective, non-competitive and non-reversible MAO inhibition."
            }
          ]
        }
      ]
    },
    {
      "title": "TCA",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Mechanism of action:"},
            {
              "value":
                  "blockade of presynaptic serotonin and noreprinephrine reuptake receptors."
            }
          ]
        },
        {
          "columns": [
            {"value": "Side effects:"},
            {"value": "inhibition of muscarinic, alpha-1, H1 receptors."}
          ]
        },
        {
          "columns": [
            {"value": "Other side effects:"},
            {
              "value":
                  "fatigue, headache, sensitivity to sunlight, nausea, seizures."
            }
          ]
        },
        {
          "columns": [
            {"value": "DESIPRAMINA, NORTRIPTILINA:"},
            {"value": "Secondary TCAs, selective norepinephrine."}
          ]
        },
        {
          "columns": [
            {"value": "AMITRIPTYLINE, IMIPRAMINE:"},
            {
              "value":
                  "Tertiary TCAs, more potent for norepinephrine but also serotonin."
            }
          ]
        }
      ]
    },
    {
      "title": "SSRIs",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Mechanism of action:"},
            {"value": "Selective inhibition of serotonin reuptake."}
          ]
        },
        {
          "columns": [
            {"value": "Side effects:"},
            {"value": "slight inhibition of muscarinic, alpha-1, H1 receptors."}
          ]
        },
        {
          "columns": [
            {
              "value":
                  "CITALOPRAM, ESCITALOPRAM, FLUOXETINE, FLUVOXAMINE, PAROXETINE, SERTRALINE."
            }
          ]
        }
      ]
    },
    {
      "title": "SNRI",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Mechanism of action:"},
            {"value": "inhibition of serotonin and norepinephrine reuptakers."}
          ]
        },
        {
          "columns": [
            {"value": "Side effects:"},
            {
              "value":
                  "mild, low affinity for H1, alpha-2, muscarinic receptors. Nausea, anorexia, insomnia, sexual dysfunction, nervousness."
            }
          ]
        },
        {
          "columns": [
            {"value": "VENLAFAXINE."}
          ]
        }
      ]
    },
    {
      "title": "Monoamino sidase",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "catabolize monoamines."}
          ]
        },
        {
          "columns": [
            {"value": "MAO-A:"},
            {"value": "norepinephrine and serotonin."}
          ]
        },
        {
          "columns": [
            {"value": "MAO-B:"},
            {"value": "dopamine, common."}
          ]
        }
      ]
    },
    {
      "title": "Receptors side effects",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Muscarinic cholinergics:"},
            {
              "value":
                  "drowsiness, dry mouth, blurred vision, constipation, urinary retention, increased heart rate."
            }
          ]
        },
        {
          "columns": [
            {"value": "Alpha-1 adrenergics:"},
            {
              "value":
                  "orthostatic hypotension, confusion, disorientation, sexual disorders."
            }
          ]
        },
        {
          "columns": [
            {"value": "Histaminergic H1:"},
            {"value": "weight gain, sedation."}
          ]
        }
      ]
    },
    {
      "title": "I WAS",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Mechanism of action:"},
            {
              "value":
                  "non-total inhibition of norepinephrine uptake, small quantities still degraded in the synaptic cleft."
            }
          ]
        },
        {
          "columns": [
            {"value": "Side effects:"},
            {
              "value":
                  "mild, low affinity for muscarinic receptors. Atropine-like effects, allergic rashes."
            }
          ]
        },
        {
          "columns": [
            {"value": "REBOXETINA."}
          ]
        }
      ]
    },
    {
      "title": "A TRAP",
      "type": "TABLE",
      "data": [
        {
          "columns": [
            {"value": "Mechanism of action:"},
            {
              "value":
                  "block presynaptic alpha-2 receptors. Block alpha-1 receptors in postsynaptic neuron, if serotonergic. Block 5-HT2 and 5-HT3 receptors."
            }
          ]
        },
        {
          "columns": [
            {"value": "Side effects:"},
            {"value": "H1, low muscaricini affinity."}
          ]
        },
        {
          "columns": [
            {"value": "MIRTAZAPINE."}
          ]
        }
      ]
    },
    {
      "title": "Psycho-oncology",
      "type": "NORMAL",
      "data": [
        {"value": "• What is psycho-oncology?"},
        {"value": "• What factors influence the development of cancer? "},
        {"value": "• What are the aims of treatment?"},
        {"value": "• What approaches are used?"},
        {"value": "• Distress"},
        {
          "value":
              "• What are some ways clinicians in this field can look after themselves?"
        },
        {"value": "• How surgery impacts people psychologically"},
        {"value": "• Common psychosocial challenges"},
        {"value": "• Greater risk of distress if"}
      ]
    },
  ]
};
